ES526297A0 - Un procedimiento para la preparacion de diarilpirazinas o triazinas - Google Patents

Un procedimiento para la preparacion de diarilpirazinas o triazinas

Info

Publication number
ES526297A0
ES526297A0 ES526297A ES526297A ES526297A0 ES 526297 A0 ES526297 A0 ES 526297A0 ES 526297 A ES526297 A ES 526297A ES 526297 A ES526297 A ES 526297A ES 526297 A0 ES526297 A0 ES 526297A0
Authority
ES
Spain
Prior art keywords
triazinas
diarilpirazinas
procedure
preparation
gaba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES526297A
Other languages
English (en)
Other versions
ES8504173A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES526297A0 publication Critical patent/ES526297A0/es
Publication of ES8504173A1 publication Critical patent/ES8504173A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/16Halogen atoms; Nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Enzymes And Modification Thereof (AREA)
ES526297A 1982-03-05 1983-10-06 Un procedimiento para la preparacion de diarilpirazinas o triazinas Expired ES8504173A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/354,982 US4513135A (en) 1982-03-05 1982-03-05 Diaryl-pyrazine derivatives affecting GABA binding

Publications (2)

Publication Number Publication Date
ES526297A0 true ES526297A0 (es) 1985-04-16
ES8504173A1 ES8504173A1 (es) 1985-04-16

Family

ID=23395746

Family Applications (2)

Application Number Title Priority Date Filing Date
ES520340A Granted ES520340A0 (es) 1982-03-05 1983-03-04 Un procedimiento para la preparacion de diarilpirazinas o triazinas.
ES526297A Expired ES8504173A1 (es) 1982-03-05 1983-10-06 Un procedimiento para la preparacion de diarilpirazinas o triazinas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES520340A Granted ES520340A0 (es) 1982-03-05 1983-03-04 Un procedimiento para la preparacion de diarilpirazinas o triazinas.

Country Status (22)

Country Link
US (2) US4513135A (es)
EP (1) EP0088593B1 (es)
JP (1) JPS58162582A (es)
KR (1) KR860000847B1 (es)
AT (1) ATE27457T1 (es)
AU (1) AU547581B2 (es)
CA (1) CA1195327A (es)
DD (1) DD207716A5 (es)
DE (1) DE3371786D1 (es)
DK (1) DK97283A (es)
ES (2) ES520340A0 (es)
FI (1) FI830708L (es)
GB (1) GB2116179B (es)
GR (1) GR78459B (es)
HU (1) HU191368B (es)
IL (1) IL68002A (es)
NZ (1) NZ203428A (es)
PH (1) PH22535A (es)
PL (1) PL240871A1 (es)
PT (1) PT76312B (es)
RO (1) RO86320B (es)
ZA (1) ZA831387B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
JPH06501926A (ja) * 1990-08-06 1994-03-03 藤沢薬品工業株式会社 複素環式化合物
GB9420010D0 (en) * 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
DK0934061T6 (en) 1996-07-24 2015-01-26 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
TWI316055B (es) * 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
KR100490893B1 (ko) * 2002-10-11 2005-05-23 (주) 비엔씨바이오팜 2-메톡시-1,3,5-트리아진 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
CA2596359A1 (en) * 2005-02-01 2006-08-10 Lake Erie Products Anti-cross threading fastener
WO2006113704A2 (en) * 2005-04-18 2006-10-26 Neurogen Corporation Subtituted heteroaryl cb1 antagonists
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
SI2531492T1 (sl) 2010-02-05 2016-08-31 Heptares Therapeutics Limited Derivati 1,2,4-triazin-4-amina
GB201106829D0 (en) 2011-04-21 2011-06-01 Proximagen Ltd Heterocyclic compounds
AR088256A1 (es) * 2011-10-08 2014-05-21 Novartis Ag Derivados de carbamato / urea como antagonistas del receptor h3
EP4302834A2 (en) 2016-07-12 2024-01-10 Revolution Medicines, Inc. 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
JP6918828B2 (ja) * 2016-11-30 2021-08-11 田辺三菱製薬株式会社 トリアジン化合物の製造方法
SG11201906412SA (en) 2017-01-23 2019-08-27 Revolution Medicines Inc Pyridine compounds as allosteric shp2 inhibitors
BR112019015075A2 (pt) 2017-01-23 2020-03-10 Revolution Medicines, Inc. Compostos bicíclicos como inibidores de shp2 alostéricos
SG11202001282UA (en) 2017-09-07 2020-03-30 Revolution Medicines Inc Shp2 inhibitor compositions and methods for treating cancer
SG11202002941WA (en) 2017-10-12 2020-04-29 Revolution Medicines Inc Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors
CA3084058A1 (en) 2017-12-15 2019-06-20 Revolution Medicines, Inc. Polycyclic compounds as allosteric shp2 inhibitors
CR20200578A (es) 2018-05-01 2021-02-22 Revolution Medicines Inc Análogos de rapamicina a c40, c28 y c32 como inhibidores de mtor
CN112368289B (zh) 2018-05-01 2024-02-20 锐新医药公司 作为mtor抑制剂的c26-连接的雷帕霉素类似物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172889A (en) * 1965-03-09 Process for the separation of z-methyl-
US3294638A (en) * 1961-06-05 1966-12-27 Warner Lambert Pharmaceutical Method and compositions employing 2-alkyl-3-piperidinopyrazines
CH480795A (de) * 1967-03-01 1969-11-15 Sandoz Ag Mittel zur Beeinflussung des Pflanzenwachstums
US3979516A (en) * 1974-01-31 1976-09-07 Eli Lilly And Company Anti-inflammatory 3-amino-5,6-diaryl-1,2,4-triazines
US4013654A (en) * 1974-01-31 1977-03-22 Eli Lilly And Company 5,6-diaryl-1,2,4-triazines
US3948894A (en) * 1974-01-31 1976-04-06 Eli Lilly And Company 3-Amino-5,6-diaryl-1,2,4-triazines
US3989831A (en) * 1974-01-31 1976-11-02 Eli Lilly And Company Topically-active anti-inflammatory 3-chloro-5,6-diaryl-1,2,4-triazines
US4081542A (en) * 1975-04-21 1978-03-28 Merck & Co., Inc. Piperazinylpyrazines
GB1493998A (en) * 1975-06-03 1977-12-07 Beecham Group Ltd Propanolamine derivatives
US4008232A (en) * 1975-06-23 1977-02-15 Eli Lilly And Company 3-Amino-5,6-diaryl-1,2,4-triazines
US4082844A (en) * 1976-02-09 1978-04-04 Merck & Co., Inc. 6-chloro-2-(1-piperazinyl)pyrazine
US4018923A (en) * 1976-03-10 1977-04-19 Eli Lilly And Company 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents
US4190725A (en) * 1976-03-10 1980-02-26 Eli Lilly And Company 5,6-Diaryl-1,2,4-triazines
US4021553A (en) * 1976-03-10 1977-05-03 Eli Lilly And Company 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents
NL7802514A (nl) * 1977-03-09 1978-09-12 Fabre Sa Pierre 5,6-diaryl-1,2,4-triazinederivaten en werkwijze ter bereiding van deze verbindingen.
IL54728A (en) * 1977-05-17 1983-06-15 Diamond Shamrock Corp Substituted 1,2,4-triazines and pharmaceutical compositions containing them
US4157392A (en) * 1977-05-17 1979-06-05 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
US4251527A (en) * 1977-05-17 1981-02-17 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines

Also Published As

Publication number Publication date
KR860000847B1 (ko) 1986-07-09
KR840004101A (ko) 1984-10-06
ES8404346A1 (es) 1984-04-16
IL68002A0 (en) 1983-06-15
CA1195327A (en) 1985-10-15
DK97283A (da) 1983-09-06
HU191368B (en) 1987-02-27
DK97283D0 (da) 1983-02-28
PT76312A (en) 1983-04-01
GB8305846D0 (en) 1983-04-07
EP0088593A3 (en) 1984-05-23
FI830708A0 (fi) 1983-03-02
RO86320A (ro) 1985-03-15
DD207716A5 (de) 1984-03-14
US4585861A (en) 1986-04-29
PL240871A1 (en) 1984-06-18
FI830708L (fi) 1983-09-06
JPS58162582A (ja) 1983-09-27
NZ203428A (en) 1986-09-10
AU1202983A (en) 1983-09-08
GB2116179B (en) 1985-09-11
US4513135A (en) 1985-04-23
EP0088593A2 (en) 1983-09-14
GR78459B (es) 1984-09-27
ES8504173A1 (es) 1985-04-16
PH22535A (en) 1988-10-17
EP0088593B1 (en) 1987-05-27
ZA831387B (en) 1984-10-31
GB2116179A (en) 1983-09-21
PT76312B (en) 1986-02-04
ATE27457T1 (de) 1987-06-15
DE3371786D1 (en) 1987-07-02
ES520340A0 (es) 1984-04-16
IL68002A (en) 1986-09-30
RO86320B (ro) 1985-03-31
AU547581B2 (en) 1985-10-24

Similar Documents

Publication Publication Date Title
ES520340A0 (es) Un procedimiento para la preparacion de diarilpirazinas o triazinas.
ES518875A0 (es) Procedimiento para la produccion de n-aril-sulfonil-n'-pirimidil-ureas.
AR240449A1 (es) Procedimiento para la preparacion de polialquilenpoliaminas no ciclicas.
ES521122A0 (es) Procedimiento para la separacion de componentes de metales pesados.
ES507307A0 (es) Procedimiento para la determinacion de colesterina.
ES528179A0 (es) Procedimiento para la obtencion de 1-fenil-3-azabiciclo(3,1,0)-hexan-2,4-dionas sustituidas
ES520847A0 (es) Procedimiento para la preparacion de 1,2,4-triazol-1-il-propionitrilos.
AR224196A1 (es) Procedimiento para la elaboracion de 4-amino-6-ter.butil-3-mercapto-1,2,4-triazin-5-ona
ES507064A0 (es) Procedimiento para la separacion de pepelote mezclado.
ES524706A0 (es) Procedimiento para la preparacion de n-(2-piridil)-(1,4-dimetil-5-(4-clorobenzoil))-2-pirrolacetamida.
ES522516A0 (es) Procedimiento para la fabricacion de aminoacetonitrilos.
ES524353A0 (es) Procedimiento para la preparacion de n-metil-n-bis-(3,4-dimetoxi-fenil-etil)-amina
ES527801A0 (es) Procedimiento para la recurticion de cueros
ES270173Y (es) Regleta para la encuadernacion de publicaciones.
ES266326Y (es) "grapa para la formacion de entramados".
ES518495A0 (es) Procedimiento para la obtencion de 2-bromometil-2-(2,4-diclorofenil)-4-hidroximetil-1,3-dioxolano.
ES515688A0 (es) Procedimiento para la preparacion de 6,7-dimetoxiquinazolinas 2,4-disustituidas.
ES512766A0 (es) "procedimiento para la fabricacion de bayetas".
ES496300A0 (es) Procedimiento para la preparacion de eteres 2,2,2-trifluoro-etil arilicos
ES517094A0 (es) Procedimiento para la obtencion de colorantes basicos modificados.
ES512749A0 (es) "metodo para la preparacion de 2-tiometil-furanos 5-substituidos".
ES512566A0 (es) Procedimiento para la fabricacion de la esencia de perla brillante.
ES515925A0 (es) "procedimiento para la produccion de estilben-4,4'-dialdehido".
ES509162A0 (es) "procedimiento para la obtencion de heparinas purificadas".
ES262582Y (es) "cantonera para la formacion de muebles".